Macter International Limited (PSX:MACTER)
Pakistan
· Delayed Price · Currency is PKR 276.83
-4.99 (-1.77%)
At close: Apr 28, 2026
Macter International Revenue
Macter International had revenue of 2.91B PKR in the quarter ending March 31, 2026, with 14.63% growth. This brings the company's revenue in the last twelve months to 11.95B, up 20.83% year-over-year. In the fiscal year ending June 30, 2025, Macter International had annual revenue of 10.36B with 29.91% growth.
Revenue (ttm)
11.95B
Revenue Growth
+20.83%
P/S Ratio
1.06
Revenue / Employee
9.33M
Employees
1,282
Market Cap
12.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 10.36B | 2.39B | 29.91% |
| Jun 30, 2024 | 7.97B | 1.05B | 15.14% |
| Jun 30, 2023 | 6.93B | 1.31B | 23.42% |
| Jun 30, 2022 | 5.61B | 239.05M | 4.45% |
| Jun 30, 2021 | 5.37B | -331.94M | -5.82% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ferozsons Laboratories | 22.22B |
| Citi Pharma | 14.10B |
| Otsuka Pakistan | 4.15B |
| Highnoon Laboratories | 27.71B |
| AGP Limited | 28.89B |
| The Searle Company | 33.26B |
| Abbott Laboratories (Pakistan) | 75.76B |
| GlaxoSmithKline Pakistan | 65.90B |